FDA Approved: ZYNLONTA — Supplemental Application (ADC Therapeutics America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZYNLONTA (loncastuximab tesirine) filed by ADC Therapeutics America, Inc., effectively updating/expanding the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Zynlonta (loncastuximab tesirine)

Snippet

SUPPL AP for ZYNLONTA (LONCASTUXIMAB TESIRINE)